Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin 

The Stevens Lecture - 2022: Curing metastatic solid tumours with immune checkpoint inhibitors - a reality in 2022? By Professor James Larkin. Recorded on Tuesday 17 May at the Royal Society of Medicine as part of the Royal Society of Medicine's public events programme.
Professor James Larkin, Consultant Medical Oncologist from The Royal Marsden Hospital in London, provides an insightful presentation into the looming reality of curing metastatic solid tumours with immune checkpoint inhibitors and the possible outcomes of this prospect for millions of patients around the world.
In the last 15 years, immune checkpoint inhibitors have been developed clinically for the treatment of cancer and these drugs are approved for the treatment of a number of different tumour types. In certain types of cancer such as melanoma, outcomes have been transformed and the possibility of cure of metastatic disease appears to be a realistic prospect.